-
Ethyl 4-methyl-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxylate
Ethyl 4-methyl -5-{2-(trifluoromethyl) phenyl} 1H-pyrrole -3-carboxylate, CAS 1631030-76-6, purity ≥ 98%, is a key pyrrole intermediate in the synthesis of drugs such as oxalone. Relying on customized synthesis platform and strict quality control system, Shanghai Lizhuo Pharmaceutical provides st...Read more -
(5S)-1-(2-Hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxylic acid
(5S)-1-(2-hydroxyethyl)-4-methyl -5-[2-(trifluoromethyl) phenyl]-1H-pyrrole -3-carboxylic acid (CAS 1632002-11-9) is a key intermediate and impurity reference substance of oxalone (Esaxerenone), with a purity of 99%, which is suitable for pharmaceutical research and development and impurity mass ...Read more -
1-(2-Hydroxyethyl)-4-methyl-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxylic acid
1-(2-Hydroxyethyl)-4-methyl -5-(2-(trifluoromethyl) phenyl)-1H-pyrrole-3-carboxylic acid (CAS 1631030-72-2), molecular formula Cdecision NO, molecular weight 313.27, conventional purity ≥ 98%. The trifluoromethyl substituted pyrrole carboxylic acid skeleton is an important pharmaceutical intermed...Read more -
7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine: A Versatile Pharmaceutical Building Block
Product Introduction 7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine is a brominated fused heterocyclic compound used as a building block in pharmaceutical and medicinal chemistry synthesis. The molecule contains a pyridine ring fused with a saturated 1,4-oxazine ring. Its structure also feature...Read more -
7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one: A Fused Heterocyclic Pharmaceutical Intermediate
Product Overview 7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one is a brominated fused heterocyclic compound used as a building block in pharmaceutical and medicinal chemistry research. Its molecular structure contains a pyridine ring fused with an oxazinone ring, forming a bicyclic heteroaromatic ...Read more -
7-Bromo-8-methyl Pyrido[2,3-b][1,4]oxazin-2-one: A Fused Heterocyclic Intermediate
Introduction 7-Bromo-8-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one is a fused nitrogen- and oxygen-containing heterocyclic compound with potential value in pharmaceutical intermediate synthesis. Its structure integrates a pyridine ring and an oxazinone ring into a fused bicyclic system. The mole...Read more -
Brigatinib Phosphine Oxide Intermediate CAS 1197953-49-3: A Pyrimidine Building Block
The design of targeted kinase inhibitors frequently combines heteroaromatic rings with specialized functional groups that help define the molecular architecture. In Brigatinib, the dimethylphosphine oxide group is a distinctive structural feature. (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dime...Read more -
Brigatinib Aniline Intermediate CAS 761440-75-9: A Key Piperazine-Piperidine Building Block
The synthesis of complex kinase inhibitors often requires the assembly of several distinct molecular fragments. In Brigatinib, an important structural component is a substituted aniline bearing a methoxy group and a nitrogen-rich piperidine-piperazine side chain. 2-Methoxy-4-(4-(4-methylpiperazin...Read more -
Boc-Risdiplam CAS 2133298-74-3: A Protected Advanced Intermediate for Risdiplam Synthesis
Advanced pharmaceutical intermediates often contain most of the structural complexity of the final active ingredient. Their role is to provide a controlled platform for the final stages of molecular assembly, protection, deprotection, and purification. Boc-Risdiplam (CAS 2133298-74-3) is a repres...Read more -
3-Amino-5-bromo-2-hydroxy-4-methylpyridine: A Versatile Halogenated Pyridine Building Block
Product Overview 3-Amino-5-bromo-2-hydroxy-4-methylpyridine is a multifunctional halogenated heteroaromatic compound used as a building block in pharmaceutical and medicinal chemistry research. Its molecular structure combines an amino group, a hydroxyl-substituted pyridine ring, a methyl substit...Read more -
6-Chloro-4-Methylpyridazin-3-Amine: A Key Pyridazine Building Block for Risdiplam Synthesis
The construction of fused nitrogen-containing heterocycles is an important part of modern pharmaceutical chemistry. In the development of Risdiplam, a key structural feature is the 2,8-dimethylimidazo[1,2-b]pyridazine fragment. Preparing this fused heterocyclic system requires a suitably substitu...Read more -
2-(2-Fluoro-4-iodoanilino)-3,4-difluorobenzoic Acid: A Mirdametinib Intermediate
A well-designed pharmaceutical intermediate often combines several functional features in one molecular structure. 2-(2-Fluoro-4-iodoanilino)-3,4-difluorobenzoic acid (CAS 391211-97-5) is an example: it contains a fluorinated diarylamine framework, an iodine substituent, and a carboxylic acid gro...Read more
